DENTSPLY SIRONA (NASDAQ:XRAY) Earns Neutral Rating from Piper Sandler

Piper Sandler reiterated their neutral rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report published on Friday, Benzinga reports. The brokerage currently has a $32.00 price target on the medical instruments supplier’s stock, down from their previous price target of $35.00.

Several other research firms have also weighed in on XRAY. Needham & Company LLC cut their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a report on Friday. SVB Leerink initiated coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an outperform rating and a $42.00 target price on the stock. Barrington Research restated an outperform rating and issued a $41.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. StockNews.com raised DENTSPLY SIRONA from a hold rating to a buy rating in a research report on Friday, January 19th. Finally, Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a research report on Friday. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus price target of $35.89.

DENTSPLY SIRONA Stock Down 0.3 %

Shares of DENTSPLY SIRONA stock opened at $28.29 on Friday. The business has a fifty day simple moving average of $32.13 and a 200 day simple moving average of $32.71. The stock has a market cap of $5.87 billion, a PE ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. The company has a quick ratio of 0.95, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 12 month low of $26.27 and a 12 month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. The company had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.39 EPS. Research analysts predict that DENTSPLY SIRONA will post 2.04 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio is -145.45%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in XRAY. Principal Securities Inc. acquired a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. VisionPoint Advisory Group LLC grew its position in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 395 shares during the period. Headlands Technologies LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $30,000. Parkside Financial Bank & Trust increased its stake in shares of DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at about $47,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.